Top

Published in:

01-11-2015 | Genetics (AP Morris, Section Editor)

Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases

Authors: Jeffrey D. Roizen, Jonathan P. Bradfield, Hakon Hakonarson

Published in: Current Diabetes Reports | Issue 11/2015

Abstract

Type 1 diabetes mellitus (T1DM) is the most common autoimmune disease in pediatrics with a prevalence of roughly 1 in 500 children in the USA. Genome-wide association studies have identified more than 50 variants associated with increased risk for type 1 diabetes. Comparison of these variants with those identified in other autoimmune diseases reveals three important findings: (1) there is a high degree of overlap in implicated variants in diseases with similar pathophysiology, (2) in diseases with differing pathophysiology the same variants are often implicated in opposite roles, (3) in diseases with differing pathophysiology that have many non-overlapping or oppositely implicated variants there are still several variants which are overlapping or shared. Thus, the genetic overlap between T1DM and other autoimmune diseases forms the basis for our understanding of druggable targets in type 1 diabetes.

1.•

Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–86. doi:10.1001/jama.2014.3201. Recent work describing the increasing prevalence of diabetes (both type 1 and type 2) in the pediatric population from 2001–2009. PubMedCentralCrossRefPubMed

Dassau E, Brown SA, Basu A, et al. Adjustment of open-loop settings to improve closed-loop results in type 1 diabetes: a multicenter randomized trial. J Clin Endocrinol Metab. 2015. doi:10.1210/jc.2015-2081.PubMed

Gingras V, Rabasa-Lhoret R, Messier V, et al. Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial. Diabete Metab. 2015. doi:10.1016/j.diabet.2015.05.001.PubMed

Pagliuca FW, Millman JR, Gurtler M, et al. Generation of functional human pancreatic beta cells in vitro. Cell. 2014;159(2):428–39. doi:10.1016/j.cell.2014.09.040.CrossRefPubMed

Khosravi-Maharlooei M, Hajizadeh-Saffar E, Tahamtani Y, et al. Islet transplantation for type 1 diabetes: so close and yet so far away. Eur J Endocrinol. 2015. doi:10.1530/eje-15-0094.PubMed

Tomei AA, Villa C, Ricordi C. Development of an encapsulated stem cell-based therapy for diabetes. Expert Opin Biol Ther. 2015:1-16. doi:10.1517/14712598.2015.1055242.

Lehmann R, Graziano J, Brockmann J, et al. Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up. Diabetes Care. 2015;38(5):752–9. doi:10.2337/dc14-1686.CrossRefPubMed

Park KT, Jun H, Kim MG, et al. Simultaneous pancreas-kidney transplantation from living donor using hand-assisted laparoscopic donor surgery: single-center experience. Transplant Proc. 2015;47(4):1096–8. doi:10.1016/j.transproceed.2014.10.063.CrossRefPubMed

Polychronakos C, Li Q. Understanding type 1 diabetes through genetics: advances and prospects. Nat Rev Genet. 2011;12(11):781–92. doi:10.1038/nrg3069.CrossRefPubMed

10.

Tomlinson MJ, Pitsillides A, Pickin R, et al. Fine mapping and functional studies of risk variants for type 1 diabetes at chromosome 16p13.13. Diabetes. 2014;63(12):4360–8. doi:10.2337/db13-1785.CrossRefPubMed

11.••

Onengut-Gumuscu S, Chen WM, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381–6. doi:10.1038/ng.3245. Recent study that used the overlap of finely mapped SNPs and ENCODE data to identify likely causal SNPs for T1DM and other autoimmune diseases.PubMedCentralCrossRefPubMed

12.

Bradfield JP, Qu HQ, Wang K, et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 2011;7(9):e1002293. doi:10.1371/journal.pgen.1002293.PubMedCentralCrossRefPubMed

13.•

Wang K, Baldassano R, Zhang H, et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet. 2010;19(10):2059–67. doi:10.1093/hmg/ddq078. Early comparative study that identified oppositely oriented associations in T1DM and inflammatory bowel disease.PubMedCentralCrossRefPubMed

14.

Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43(12):1193–201. doi:10.1038/ng.998.PubMedCentralCrossRefPubMed

15.••

Fortune MD, Guo H, Burren O, Schofield E, Walker NM, Ban M, et al. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat Genet. 2015. doi:10.1038/ng.3330. Uses baysean inference to identify likely causal SNPs across several autoimmune diseases. PubMedCentral

16.

Eaton WW, Rose NR, Kalaydjian A, et al. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1–9. doi:10.1016/j.jaut.2007.05.002.PubMedCentralCrossRefPubMed

17.

Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350(20):2068–79. doi:10.1056/NEJMra030158.CrossRefPubMed

18.

Yang S, Fujikado N, Kolodin D, et al. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science. 2015;348(6234):589–94. doi:10.1126/science.aaa7017.CrossRefPubMed

19.

Aronson R, Gottlieb PA, Christiansen JS, et al. Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes. Diabetes Care. 2014;37(10):2746–54. doi:10.2337/dc13-0327.PubMedCentralCrossRefPubMed

20.

Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76(4):561–71. doi:10.1086/429096.PubMedCentralCrossRefPubMed

21.

Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18–20. doi:10.1038/83707.CrossRefPubMed

22.

Huber A, Menconi F, Corathers S, et al. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008;29(6):697–725. doi:10.1210/er.2008-0015.PubMedCentralCrossRefPubMed

23.•

Hakonarson H, Grant SF, Bradfield JP, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature. 2007;448(7153):591–4. doi:10.1038/nature06010. One of the two first GWAS of T1DM. CrossRefPubMed

24.•

Hakonarson H, Qu HQ, Bradfield JP, et al. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes. 2008;57(4):1143–6. doi:10.2337/db07-1305. Used larger sample size to identify rare risk-associated variant in T1D. CrossRefPubMed

25.

Concannon P, Onengut-Gumuscu S, Todd JA, et al. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes. 2008;57(10):2858–61. doi:10.2337/db08-0753.PubMedCentralCrossRefPubMed

26.

Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78. doi:10.1038/nature05911.CrossRef

27.

Grant SF, Qu HQ, Bradfield JP, et al. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes. 2009;58(1):290–5. doi:10.2337/db08-1022.PubMedCentralCrossRefPubMed

28.

Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857–64. doi:10.1038/ng2068.PubMedCentralCrossRefPubMed

29.

Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41(6):703–7. doi:10.1038/ng.381.PubMedCentralCrossRefPubMed

30.

Qu HQ, Bradfield JP, Li Q, et al. In silico replication of the genome-wide association results of the Type 1 Diabetes Genetics Consortium. Hum Mol Genet. 2010;19(12):2534–8. doi:10.1093/hmg/ddq133.CrossRefPubMed

31.

Cooper JD, Smyth DJ, Smiles AM, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet. 2008;40(12):1399–401. doi:10.1038/ng.249.PubMedCentralCrossRefPubMed

32.

Wallace C, Smyth DJ, Maisuria-Armer M, et al. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet. 2010;42(1):68–71. doi:10.1038/ng.493.PubMedCentralCrossRefPubMed

33.

Wei Z, Wang K, Qu HQ, et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet. 2009;5(10):e1000678. doi:10.1371/journal.pgen.1000678.PubMedCentralCrossRefPubMed

34.

Eleftherohorinou H, Wright V, Hoggart C, et al. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One. 2009;4(11):e8068. doi:10.1371/journal.pone.0008068.PubMedCentralCrossRefPubMed

35.

Tuller T, Atar S, Ruppin E, et al. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes Immun. 2013;14(2):67–82. doi:10.1038/gene.2012.55.CrossRefPubMed

36.

Ferreira RC, Simons HZ, Thompson WS, et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia. 2015;58(4):781–90. doi:10.1007/s00125-015-3509-8.PubMedCentralCrossRefPubMed

37.

Dendrou CA, Plagnol V, Fung E, et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet. 2009;41(9):1011–5. doi:10.1038/ng.434.PubMedCentralCrossRefPubMed

38.•

Guo H, Fortune MD, Burren OS, et al. Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases. Hum Mol Genet. 2015;24(12):3305–13. doi:10.1093/hmg/ddv077. Integrates eQTL data to identify likely causal variants. PubMedCentralCrossRefPubMed

39.

Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet. 2006;38(6):617–9. doi:10.1038/ng1800.CrossRefPubMed

40.

Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984;33(2):176–83.CrossRefPubMed

41.

Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36(4):337–8. doi:10.1038/ng1323.CrossRefPubMed

42.

Lowe CE, Cooper JD, Brusko T, et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet. 2007;39(9):1074–82. doi:10.1038/ng2102.CrossRefPubMed

43.

Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012;44(12):1336–40. doi:10.1038/ng.2462.PubMedCentralCrossRefPubMed

44.••

Farh KK, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337–43. doi:10.1038/nature13835. Generated and used an algorhythm (PICS) to identify likely causal variants in automimmune disease. PubMedCentralCrossRefPubMed

45.

Hrdlickova B, Westra HJ, Franke L, Wijmenga C. Celiac disease: moving from genetic associations to causal variants. Clin Genet. 2011;80(3):203–313. doi:10.1111/j.1399-0004.2011.01707.x.CrossRefPubMed

46.•

Wellcome Trust Case Control C, Maller JB, McVean G, et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet. 2012;44(12):1294–301. doi:10.1038/ng.2435. This is an early paper looking at specific shared loci underlying auto-immunoe disease. CrossRef

47.•

Andreassen OA, Desikan RS, Wang Y, et al. Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms. PLoS One. 2015;10(4):e0123057. doi:10.1371/journal.pone.0123057. Identifies common loci shared between autoimmune disease and lipid dysregulation. PubMedCentralCrossRefPubMed

Title: Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases
Authors: Jeffrey D. Roizen
Jonathan P. Bradfield
Hakon Hakonarson
Publication date: 01-11-2015
Publisher: Springer US
Published in: Current Diabetes Reports / Issue 11/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0668-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2015

Diabetes-Related Dysfunction of the Small Intestine and the Colon: Focus on Motility

Strategies for Improving Cardiovascular Health in Women With Diabetes Mellitus: a Review of the Evidence

Genes Affecting β-Cell Function in Type 1 Diabetes

Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

Is There a Relationship Between Oral Health and Diabetic Neuropathy?

Targeting Memory T Cells in Type 1 Diabetes

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage